---
figid: PMC4441360__pone.0128159.g006
figlink: /pmc/articles/PMC4441360/figure/pone.0128159.g006/
number: F6
caption: c-Met activates MAP kinase (Raf/Mek/Erk) and PI3K/Akt signaling to induce
  HCC growth and survival. The PI3K/Akt arm of the c-Met signaling pathway normally
  suppresses EGFR pathway members (i.e. TGF-α and ErbB3), thus suppressing EGFR pathway
  activity. Suppression of c-Met signaling leads to loss of PI3K/Akt activity, and
  thus up-regulation of TGF-α and ErbB3 members of the EGFR signaling pathway. ErbB3
  can heterodimerize with ErbB1 (EGFR), forming a potent EGFR receptor. Additionally,
  EGFR ligand TGF-α stimulates EGFR pathway activation, leading to cancer cell growth
  and survival. Targeting both EGFR and c-Met suppress pathway cross talk and leads
  to greater suppression of tumor growth and survival.
pmcid: PMC4441360
papertitle: The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon
  c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma.
reftext: Steven N. Steinway, et al. PLoS One. 2015;10(5):e0128159.
pmc_ranked_result_index: '444'
pathway_score: 0.8987204
filename: pone.0128159.g006.jpg
figtitle: EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met
  Inhibition in Human c-Met+ Hepatocellular Carcinoma
year: '2015'
organisms:
- Mus musculus
- Diaporthe sclerotioides
- Sequoia sempervirens
- Homo sapiens
ndex: 5c1d36e9-dea5-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4441360__pone.0128159.g006.html
  '@type': Dataset
  description: c-Met activates MAP kinase (Raf/Mek/Erk) and PI3K/Akt signaling to
    induce HCC growth and survival. The PI3K/Akt arm of the c-Met signaling pathway
    normally suppresses EGFR pathway members (i.e. TGF-α and ErbB3), thus suppressing
    EGFR pathway activity. Suppression of c-Met signaling leads to loss of PI3K/Akt
    activity, and thus up-regulation of TGF-α and ErbB3 members of the EGFR signaling
    pathway. ErbB3 can heterodimerize with ErbB1 (EGFR), forming a potent EGFR receptor.
    Additionally, EGFR ligand TGF-α stimulates EGFR pathway activation, leading to
    cancer cell growth and survival. Targeting both EGFR and c-Met suppress pathway
    cross talk and leads to greater suppression of tumor growth and survival.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - RAF1
  - MAPK3
  - EGFR
  - ARAF
  - MAP2K2
  - MAPK1
  - BRAF
  - MAP2K1
  - TGFA
  - SLTM
  - ERBB3
genes:
- word: Raf/Mek/Erk
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf/Mek/Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: Raf/Mek/Erk
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Raf/Mek/Erk
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Raf/Mek/Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Raf/Mek/Erk
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Raf/Mek/Erk
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: TGFA
  symbol: TGFA
  source: hgnc_symbol
  hgnc_symbol: TGFA
  entrez: '7039'
- word: c-Met
  symbol: Met
  source: hgnc_alias_symbol
  hgnc_symbol: SLTM
  entrez: '79811'
- word: ErbB3
  symbol: ERBB3
  source: hgnc_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
chemicals: []
diseases: []
figid_alias: PMC4441360__F6
redirect_from: /figures/PMC4441360__F6
figtype: Figure
---
